What is the CVSS score of CVE-2024-35433?

CVE-2024-35433 has a CVSS 3.1 base score of 8.1 (High). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N. EPSS exploitation probability: 0.5%.

Is there a public PoC exploit available for CVE-2024-35433?

Yes, a public proof-of-concept exploit is available for CVE-2024-35433. Prioritise patching immediately. EPSS: 0.5%.

Zkbio Cvsecurity CVE-2024-35433

HIGH

Improper Access Control (CWE-284)

2024-05-30 cve@mitre.org

Authentication Bypass Zkbio Cvsecurity

8.1

CVSS 3.1 · Vendor: mitre

Severity by source

Vendor (mitre) PRIMARY

8.1 HIGH

AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Primary rating from Vendor (mitre) · only source for this CVE.

CVSS VectorVendor: mitre

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

None

Lifecycle Timeline

CVE Published

May 30, 2024 - 18:15 cve.org

HIGH 8.1

DescriptionCVE.org

ZKTeco ZKBio CVSecurity 6.1.1 is vulnerable to Incorrect Access Control. An authenticated user, without the permissions of managing users, can create a new admin user.

AnalysisAI

ZKTeco ZKBio CVSecurity 6.1.1 is vulnerable to Incorrect Access Control. Rated high severity (CVSS 8.1), this vulnerability is remotely exploitable, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-284. ZKTeco ZKBio CVSecurity 6.1.1 is vulnerable to Incorrect Access Control. An authenticated user, without the permissions of managing users, can create a new admin user. Affected products include: Zkteco Zkbio Cvsecurity.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.